日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study

病理缓解率≥90%可预测接受新辅助局部区域治疗的肝细胞癌患者的生存期:一项回顾性队列研究

Ou-Yang, Li-Ying; Gan, Yi-Xiang; Zhang, Chao; Jiang, Neng; Lu, Shi-Xun; Yang, Zi-Liang; Shi, Ming; Zhang, Yao-Jun; Zhou, Zhong-Guo; Chen, Min-Shan; Yun, Jing-Ping; Xu, Li

Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma

一线PD-1抑制剂联合化疗治疗PD-L1低表达胃癌或胃食管交界处腺癌患者的临床疗效及生物标志物探索

Sun, Yu-Ting; Lu, Shi-Xun; Lai, Ming-Yu; Yang, Xia; Guan, Wen-Long; Yang, Li-Qiong; Li, Yu-Hong; Wang, Feng-Hua; Yang, Da-Jun; Qiu, Miao-Zhen

Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer

比较实体瘤疗效评价标准和肿瘤消退分级在评价胃癌术前全身治疗效果中的应用

Lai, Ming-Yu; Kang, Shi-Yang; Sun, Yu-Ting; Quan, Ting-Ting; Lu, Shi-Xun; He, Cai-Yun; Zhou, Zhi-Wei; Yang, Li-Qiong; Luo, Hui-Yan; Wang, Feng-Hua; Li, Yu-Hong; Xu, Rui-Hua; Guan, Wen-Long; Qiu, Miao-Zhen

Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis

根据EBV状态对胃癌进行分类并结合分子谱分析可以预测患者的预后。

He, Cai-Yun; Qiu, Miao-Zhen; Yang, Xin-Hua; Zhou, Da-Lei; Ma, Jiang-Jun; Long, Ya-Kang; Ye, Zu-Lu; Xu, Bo-Heng; Zhao, Qi; Jin, Ying; Lu, Shi-Xun; Wang, Zhi-Qiang; Guan, Wen-Long; Zhao, Bai-Wei; Zhou, Zhi-Wei; Shao, Jian-Yong; Xu, Rui-Hua

Observational cohort study of clinical outcome in Epstein-Barr virus associated gastric cancer patients

一项关于EB病毒相关胃癌患者临床结局的观察性队列研究

Qiu, Miao-Zhen; He, Cai-Yun; Yang, Da-Jun; Zhou, Da-Lei; Zhao, Bai-Wei; Wang, Xiao-Jian; Yang, Li-Qiong; Lu, Shi-Xun; Wang, Feng-Hua; Xu, Rui-Hua

POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim.

POH1 敲低通过 p53 和 Bim 诱导癌细胞凋亡

Wang Chun-Hua, Lu Shi-Xun, Liu Li-Li, Li Yong, Yang Xia, He Yang-Fan, Chen Shi-Lu, Cai Shao-Hang, Wang Hong, Yun Jing-Ping

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma

eEF1A1 过表达促进肝细胞癌肿瘤进展并预示预后不良

Chen, Shi-Lu; Lu, Shi-Xun; Liu, Li-Li; Wang, Chun-Hua; Yang, Xia; Zhang, Zhi-Yi; Zhang, Hui-Zhong; Yun, Jing-Ping

Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients

Pim-3作为局部晚期直肠癌患者化疗放疗耐药性的潜在预测因子

Zhang, Rong-Xin; Zhou, Zhong-Guo; Lu, Shi-Xun; Lu, Zhen-Hai; Wan, De-Sen; Pan, Zhi-Zhong; Wu, Xiao-Jun; Chen, Gong

Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.

丙酮酸激酶 M2 通过调节 Bim 稳定性来阻止细胞凋亡,并且与肝细胞癌的不良预后相关

Hu Wen, Lu Shi-Xun, Li Min, Zhang Chao, Liu Li-Li, Fu Jia, Jin Jie-Tian, Luo Rong-Zhen, Zhang Chris Zhiyi, Yun Jing-Ping

The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study

COX-2抑制剂对卡培他滨诱发的II/III期结直肠癌患者手足综合征的影响:一项II期随机前瞻性研究

Zhang, Rong-Xin; Wu, Xiao-Jun; Lu, Shi-Xun; Pan, Zhi-Zhong; Wan, De-Sen; Chen, Gong